Table 2.
The leading five co-infection pathogens pattern in 2020 to 2024(from Jan to Jun)
| Respiratory pathogens | 2020 | N=(7185) | 2021 | (N = 12722) | 2022 | (N = 12824) | 2023 | (N = 20284) | 2024(from Jan to Jun) | (N = 10999) |
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| MP&HRV | 55 | (0.8%) | NA | NA | 44 | (0.3%) | 938 | (4.6%) | 453 | (4.1%) |
| AdV&HRV | 52 | (0.7%) | 88 | (0.7%) | 68 | (0.5%) | 274 | (1.4%) | 292 | (2.7%) |
| RSV&HRV | 122 | (1.7%) | 165 | (1.3%) | 49 | (0.4%) | 264 | (1.3%) | 191 | (1.7%) |
| HPIV&HRV | 92 | (1.3%) | 188 | (1.5%) | 98 | (0.8%) | 209 | (1.0%) | 156 | (1.4%) |
| MP&AdV | NA | NA | NA | NA | NA | NA | 281 | (1.4%) | 189 | (1.7%) |
| HMPV&HRV | NA | NA | 66 | (0.5%) | 90 | (0.7%) | NA | NA | NA | NA |
| HBoV&HRV | 65 | (0.9%) | 71 | (0.6%) | NA | NA | NA | NA | NA | NA |
| Others | 156 | (2.2%) | 223 | (1.8%) | 358 | (2.8%) | 862 | (4.2%) | 629 | (5.7%) |
| All | 542 | (7.5%) | 801 | (6.3%) | 707 | (5.5%) | 2828 | (13.9%) | 1910 | (17.4%) |
NA: not available